home / stock / alks / alks quote
Last: | $24.62 |
---|---|
Change Percent: | 0.74% |
Open: | $24.55 |
Close: | $24.44 |
High: | $24.62 |
Low: | $24.3 |
Volume: | 285,657 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$24.62 | $24.55 | $24.44 | $24.62 | $24.3 | 285,657 | 04-26-2024 |
$24.44 | $24.39 | $24.44 | $24.6 | $23.89 | 1,313,171 | 04-25-2024 |
$24.65 | $24.26 | $24.65 | $24.81 | $24.16 | 1,682,172 | 04-24-2024 |
$24.26 | $24.09 | $24.26 | $24.63 | $24.06 | 1,245,764 | 04-23-2024 |
$24.07 | $24.08 | $24.07 | $24.19 | $23.7604 | 1,708,265 | 04-22-2024 |
$23.85 | $23.65 | $23.85 | $23.87 | $23.48 | 2,414,813 | 04-19-2024 |
$23.76 | $23.86 | $23.76 | $24.14 | $23.62 | 1,798,839 | 04-18-2024 |
$24.01 | $23.94 | $24.01 | $24.59 | $23.735 | 2,257,028 | 04-17-2024 |
$23.77 | $23.84 | $23.77 | $24.1 | $23.65 | 1,579,931 | 04-16-2024 |
$24.02 | $24.24 | $24.02 | $24.64 | $23.915 | 2,713,260 | 04-15-2024 |
$24.42 | $25.05 | $24.42 | $25.17 | $24.16 | 1,895,023 | 04-12-2024 |
$24.99 | $26.31 | $24.99 | $26.31 | $24.91 | 2,076,481 | 04-11-2024 |
$26.14 | $26.32 | $26.14 | $26.4199 | $25.75 | 2,030,369 | 04-10-2024 |
$26.73 | $27.29 | $26.73 | $27.56 | $26.23 | 4,113,494 | 04-09-2024 |
$25.93 | $26.24 | $25.93 | $26.38 | $25.83 | 1,221,275 | 04-08-2024 |
$26.12 | $25.76 | $26.12 | $26.42 | $25.435 | 1,780,139 | 04-05-2024 |
$25.81 | $26.59 | $25.81 | $26.78 | $25.77 | 1,260,125 | 04-04-2024 |
$26.33 | $26.76 | $26.33 | $26.88 | $26.21 | 1,266,542 | 04-03-2024 |
$26.77 | $27.04 | $26.77 | $27.15 | $26.385 | 2,384,539 | 04-02-2024 |
$27.24 | $27.13 | $27.24 | $27.39 | $26.88 | 1,306,687 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Alkermes plc Company Name:
ALKS Stock Symbol:
NASDAQ Market:
Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1 PR Newswire DUBLIN , April 24, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced initiation of the Vibrance-1 study, a pha...
Alkermes to Report First Quarter Financial Results on May 1, 2024 PR Newswire DUBLIN , April 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, Ma...
2024-04-10 09:00:04 ET Akash Tewari from Jefferies issued a price target of $50.00 for ALKS on 2024-04-10 07:44:00. The adjusted price target was set to $50.00. At the time of the announcement, ALKS was trading at $26.73. The overall price target consensus is at $31.33 w...